Clinical Trial Update: Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunologic response to an influenza vaccine delivered by jet injection versus needle-syringe completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Prophylaxis

Drugs mentioned

• PharmaJet

Snippet

Sponsor: PharmaJet, Inc. | Conditions: Influenza Prophylaxis | Phase 4 | Status: COMPLETED | Results posted: 2019-06-20